TechNavio recognizes the following companies as the key players in the Global Melanoma Therapeutics Market: Bristol-Myers Squibb Co., Merck and Co. Inc., and F. Hoffmann-La Roche Ltd. (Roche).
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”A current trend witnessed in the Global Melanoma Therapeutics market is the use of combination therapies for the treatment of melanoma. At stage IV of melanoma, tumor cells spread from its origin site to distant sites. Thus, it cannot be cured with the help of one single therapy alone. Cancer cells that are confined locally can be easily treated by surgery or radiation therapy, while cancer cells that have spread to distant sites can be killed by chemotherapy. Therefore, combination therapies help in the complete removal of tumors and the destruction of cancerous cells. For instance, chemotherapy combined with immunotherapy is the most promising therapy available for the treatment of metastatic melanoma. The combination is chosen according to the size of the tumor and the risk of recurrence.”
According to the report, one of the major drivers is the presence of new promising drugs in the pipeline. There were only three drugs in the market till 2011. With the launch of three new drugs in 2011, the market size increased considerably. Thus, with more drugs in the pipeline, the market will experience positive growth in the future.
Further, the report states that the biggest challenge that the Global Melanoma Therapeutics market is facing is the availability of alternative treatment options other than drugs such as surgery and radiation therapy. These alternative treatments limit the consumption of drugs.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are AB Science S.A., Amgen Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co. Ltd., GlaxoSmithKline plc, Pfizer Inc., and Vical Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-melanoma-therapeutics-market-201…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Engineering market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report “ Global Melanoma Therapeutics Market 2012-2016
